根据最新的财务报表(Form-10K),Invitro International 的总资产为 $0,净损失为 $0
IVRO 的关键财务比率是什么?
Invitro International 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
Invitro International 的收入按细分市场或地理位置如何划分?
Invitro International 最大收入来源是 In-vitro (Non-animal) Consumer, Product, and Environmental Safety Test Method,在最近的收益报告中收入为 878,937。就地区而言, United States 是 Invitro International 的主要市场,收入为 520,705。
Invitro International 是否盈利?
不,根据最新的财务报表,Invitro International 的净损失为 $0
Invitro International 有负债吗?
不,Invitro International 的负债为 0
Invitro International 的流通股有多少?
Invitro International 的总流通股为 0
关键数据
前收盘价
$0.0825
开盘价
$0.0702
当日区间
$0.06 - $0.0898
52周范围
$0.0315 - $0.16
交易量
35.0K
平均成交量
44.3K
股息收益率
--
每股收益(TTM)
0.00
市值
$1.8M
什么是 IVRO?
InVitro International engages in development and commercialization globally of test kits and laboratory services. The company is headquartered in Placentia, California. The Company’s testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its technologies are commercialized through test kits and laboratory services globally. The company operates in various industry segments providing in-vitro (non-animal) consumer, product and environmental safety test methods to customers in the cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation industries. Its Irritection Assay System is a vitro test method which uses changes of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures and product formulations. Its Irritection Assay System consists of an ocular test, Ocular Irritection and dermal test, Dermal Irritection. Corrositex is a non-animal test that determines skin corrosivity.